{
    "2020-04-21": [
        [
            {
                "time": "",
                "original_text": "【智飞生物|年报点评】2019年业绩符合预期，重磅品种即将获批上市【安信医药马帅团队】",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "业绩",
                        "重磅品种",
                        "获批上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "渝股点金｜智飞生物：年报净利同比大幅 近期持续强势",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "净利",
                        "同比",
                        "大幅增长",
                        "近期强势"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "鹰眼预警:智飞生物毛利率净利率双降 应收存货占比高 盈利能力下降",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "毛利率",
                        "净利率",
                        "双降",
                        "应收存货",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物2019年营收突破百亿元大关",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2019年",
                        "营收",
                        "突破",
                        "百亿元大关"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物2019年营收同比翻倍 九价HPV疫苗批签发量同比增长173.35%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2019年",
                        "营收",
                        "同比翻倍",
                        "九价HPV疫苗",
                        "批签发量",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：业绩持续高增长，重磅产品进入密集收获期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "高增长",
                        "重磅产品",
                        "密集收获期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "渝股看台｜智飞生物去年净赚23亿 多项疫苗取得进展",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "去年",
                        "净赚",
                        "23亿",
                        "多项疫苗",
                        "取得进展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}